Tag: ALS

Spinogrnix awarded $1 million to advance ALS therapy clinical testing

Spinogrnix awarded $1 million to advance ALS therapy clinical testing

The US Department of Defence has recently awarded the Australian Spinogenix, an Australian biopharmaceutical company that develops therapeutics for diseases causing synaptic loss and dysfunction, a large grant to help advance the development and testing of an Amyotrophic Lateral Sclerosis (ALS) therapy. The $1 million USD grant is set to support SPG302, Spinogenix’s new potential […]

Hey! Are you enjoying NYCTastemakers? Make sure to join our mailing list for NYCTM and never miss the chance to read all of our articles!